Anti-KLOTB/ KLB/ BKL monoclonal antibody

Anti-KLOTB/ KLB/ BKL antibody for FACS & in-vivo assay

Target products collectionGo to KLB/KLB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T14110-Ab-1/ GM-Tg-hg-T14110-Ab-2Anti-Human KLB monoclonal antibodyHuman
GM-Tg-rg-T14110-Ab-1/ GM-Tg-rg-T14110-Ab-2Anti-Rat KLB monoclonal antibodyRat
GM-Tg-mg-T14110-Ab-1/ GM-Tg-mg-T14110-Ab-2Anti-Mouse KLB monoclonal antibodyMouse
GM-Tg-cynog-T14110-Ab-1/ GM-Tg-cynog-T14110-Ab-2Anti-Cynomolgus/ Rhesus macaque KLB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T14110-Ab-1/ GM-Tg-felg-T14110-Ab-2Anti-Feline KLB monoclonal antibodyFeline
GM-Tg-cang-T14110-Ab-1/ GM-Tg-cang-T14110-Ab-2Anti-Canine KLB monoclonal antibodyCanine
GM-Tg-bovg-T14110-Ab-1/ GM-Tg-bovg-T14110-Ab-2Anti-Bovine KLB monoclonal antibodyBovine
GM-Tg-equg-T14110-Ab-1/ GM-Tg-equg-T14110-Ab-2Anti-Equine KLB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T14110-Ab-1/ GM-Tg-hg-T14110-Ab-2; GM-Tg-rg-T14110-Ab-1/ GM-Tg-rg-T14110-Ab-2;
GM-Tg-mg-T14110-Ab-1/ GM-Tg-mg-T14110-Ab-2; GM-Tg-cynog-T14110-Ab-1/ GM-Tg-cynog-T14110-Ab-2;
GM-Tg-felg-T14110-Ab-1/ GM-Tg-felg-T14110-Ab-2; GM-Tg-cang-T14110-Ab-1/ GM-Tg-cang-T14110-Ab-2;
GM-Tg-bovg-T14110-Ab-1/ GM-Tg-bovg-T14110-Ab-2; GM-Tg-equg-T14110-Ab-1/ GM-Tg-equg-T14110-Ab-2
Products NameAnti-KLB monoclonal antibody
Formatmab
Target NameKLB
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KLB benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species KLOTB/ KLB/ BKL VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-T14110-Ag-1klotho beta (KLB) protein


    Target information

    Target IDGM-T14110
    Target NameKLB
    Gene ID152831,83379,289625,699115,479110,101083930,514925,100064228
    Gene Symbol and SynonymsAABR07015003.1,betaKlotho,BKL,KLB,Klb-ps1,RGD1308227
    Uniprot AccessionQ86Z14
    Uniprot Entry NameKLOTB_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000134962
    Target ClassificationN/A

    The target: KLB, gene name: KLB, also named as BKL. Enables fibroblast growth factor binding activity and fibroblast growth factor receptor binding activity. Predicted to be involved in fibroblast growth factor receptor signaling pathway. Predicted to act upstream of or within positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway and positive regulation of cell population proliferation. Predicted to be located in plasma membrane. Predicted to be active in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.